Qiaoyu Xu

Title: Qiaoyu Xu: Innovator in Antibody Drug Conjugates

Introduction

Qiaoyu Xu is a prominent inventor based in Yantai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. With a total of 3 patents, his work focuses on innovative solutions for cancer treatment.

Latest Patents

Qiaoyu Xu's latest patents include the following:

1. **Anti-mesothelin antibody and antibody drug conjugate thereof** - This invention discloses an antibody drug conjugate that targets mesothelin (MSLN). It also includes a method for making the antibody drug conjugate (ADC) and introduces a novel MSLN antibody or a functional fragment comprising engineered heavy and light chains.

2. **Anti-HER2 antibody and conjugate thereof** - This patent reveals an anti-HER2 antibody and its conjugate with small molecule medicine. It also discusses the uses of the antibody and its conjugate in preparing medicine for treating tumors.

Career Highlights

Qiaoyu Xu has worked with notable companies in the biotechnology sector, including Remegen Ltd. and Remegen Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

Some of his coworkers include Jianmin Fang and Changjiang Huang. Their collaboration has likely played a role in the success of his projects and patents.

Conclusion

Qiaoyu Xu is a key figure in the field of antibody drug conjugates, with a focus on developing targeted therapies for cancer treatment. His innovative patents and collaborations highlight his commitment to advancing medical science.